Neurogene press release: Rapid enrolment and expansion
Neurogene has published a press release today with an update to their Rett syndrome
Menu
Neurogene has published a press release today with an update to their Rett syndrome
Taysha Gene Therapies has announced several updates to the TSHA-102 program through a press
We are delighted to welcome, Oly Freeman to the board of Trustees at Reverse
2024 is already proving to be an exciting year for the UK Rett Community with
by Andy Stevenson I recently held my first fundraising workshop on Zoom. Titled ‘The
by Rachael Stevenson Last week, gene therapy companies Neurogene Inc and Taysha Gene Therapies
On 10 January 2024, Taysha Gene Therapies announced a press release sharing the news
On 5 January 2024, Neurogene announced a business update and 2024 outlook. This news
A huge thank you to everybody who helped us reach our target and more
September 2023 Emerging Gene Therapies Bitesize – Session 1 Reverse Rett CEO Rachael Stevenson
Much is going to be required of our very small, rare disease organisation at
November 30th 2023-Neurogene has announced today that they have dosed the first two female